Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 2750 entries
Sorted by: Best Match Show Resources per page
Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Fares S, Feki M, Khouaja-Mokrani C, Sethom MM, Jebnoun S, Kaabachi N.
PMID: 25115165
J Matern Fetal Neonatal Med. 2015 Jul;28(11):1324-1328. doi: 10.3109/14767058.2014.953922. Epub 2014 Sep 10.

OBJECTIVE: To look at changes in plasma vitamin A, E and D concentrations during the early postnatal life and to study their link with growth and mortality in Tunisian very low birth weight (VLBW) infants.PATIENTS AND METHODS: A cohort...

Cite
Fares S, Feki M, Khouaja-Mokrani C, et al. Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants. J Matern Fetal Neonatal Med. 2014;28(11):1324-1328doi: 10.3109/14767058.2014.953922.
Fares, S., Feki, M., Khouaja-Mokrani, C., Sethom, M. M., Jebnoun, S., & Kaabachi, N. (2015). Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 28(11), 1324-1328. https://doi.org/10.3109/14767058.2014.953922
Fares, Samira, et al. "Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. 28,11 (2015): 1324-1328. doi: https://doi.org/10.3109/14767058.2014.953922
Fares S, Feki M, Khouaja-Mokrani C, Sethom MM, Jebnoun S, Kaabachi N. Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants. J Matern Fetal Neonatal Med. 2015 Jul;28(11):1324-1328. doi: 10.3109/14767058.2014.953922. Epub 2014 Sep 10. PMID: 25115165.
Copy Download .nbib Format: NLM
Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine.

Redox report : communications in free radical research

Wasil M, Kelly FJ.
PMID: 27405835
Redox Rep. 1995 Nov;1(5):361-7. doi: 10.1080/13510002.1995.11747012.

The angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine, protect myocardial tissue from ischaemia/reperfusion-induced injury. Although both drugs have well established, independent mechanisms of cardiac protection, they may also have antioxidant activity which could contribute to their...

Cite
Wasil M, Kelly FJ. Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox Rep. 1995;1(5):361-7doi: 10.1080/13510002.1995.11747012.
Wasil, M., & Kelly, F. J. (1995). Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox report : communications in free radical research, 1(5), 361-7. https://doi.org/10.1080/13510002.1995.11747012
Wasil, M, and Kelly, F J. "Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine." Redox report : communications in free radical research vol. 1,5 (1995): 361-7. doi: https://doi.org/10.1080/13510002.1995.11747012
Wasil M, Kelly FJ. Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox Rep. 1995 Nov;1(5):361-7. doi: 10.1080/13510002.1995.11747012. PMID: 27405835.
Copy Download .nbib Format: NLM
Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.

Research and reports in urology

Paulis G, Barletta D, Turchi P, Vitarelli A, Dachille G, Fabiani A, Gennaro R.
PMID: 26770906
Res Rep Urol. 2015 Dec 31;8:1-10. doi: 10.2147/RRU.S97194. eCollection 2016.

Peyronie's disease (PD) is a chronic disorder involving the tunica albuginea surrounding the corpora cavernosa of the penis. A conservative treatment is indicated in the first stage of disease. The aim of this study was to assess the therapeutic...

Cite
Paulis G, Barletta D, Turchi P, et al. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Res Rep Urol. 2015;8:1-10doi: 10.2147/RRU.S97194.
Paulis, G., Barletta, D., Turchi, P., Vitarelli, A., Dachille, G., Fabiani, A., & Gennaro, R. (2016). Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Research and reports in urology, 81-10. https://doi.org/10.2147/RRU.S97194
Paulis, Gianni, et al. "Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study." Research and reports in urology vol. 8 (2016): 1-10. doi: https://doi.org/10.2147/RRU.S97194
Paulis G, Barletta D, Turchi P, Vitarelli A, Dachille G, Fabiani A, Gennaro R. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Res Rep Urol. 2015 Dec 31;8:1-10. doi: 10.2147/RRU.S97194. eCollection 2016. PMID: 26770906; PMCID: PMC4706125.
Copy Download .nbib Format: NLM
Pharmacological agents for nonalcoholic steatohepatitis.

Hepatology international

Guillaume M, Ratziu V.
PMID: 26202298
Hepatol Int. 2013 Dec;7:833-41. doi: 10.1007/s12072-013-9482-8. Epub 2013 Nov 19.

The rationale for specific pharmacologic therapy in nonalcoholic steatohepatitis (NASH) is determined by the potential for disease progression and the difficulties, in many patients, to successfully implement diet and lifestyle changes in the long term. Because they correct insulin...

Cite
Guillaume M, Ratziu V. Pharmacological agents for nonalcoholic steatohepatitis. Hepatol Int. 2013;7:833-41doi: 10.1007/s12072-013-9482-8.
Guillaume, M., & Ratziu, V. (2013). Pharmacological agents for nonalcoholic steatohepatitis. Hepatology international, 7833-41. https://doi.org/10.1007/s12072-013-9482-8
Guillaume, Maeva, and Ratziu, Vlad. "Pharmacological agents for nonalcoholic steatohepatitis." Hepatology international vol. 7 (2013): 833-41. doi: https://doi.org/10.1007/s12072-013-9482-8
Guillaume M, Ratziu V. Pharmacological agents for nonalcoholic steatohepatitis. Hepatol Int. 2013 Dec;7:833-41. doi: 10.1007/s12072-013-9482-8. Epub 2013 Nov 19. PMID: 26202298.
Copy Download .nbib Format: NLM
Ataxia with vitamin e deficiency in norway.

Journal of movement disorders

Elkamil A, Johansen KK, Aasly J.
PMID: 25614784
J Mov Disord. 2015 Jan;8(1):33-6. doi: 10.14802/jmd.14030. Epub 2015 Jan 13.

OBJECTIVE: Ataxia with vitamin E deficiency (AVED) is a rare autosomal recessive neurological disorder which usually starts in childhood. The clinical presentation is very similar to Friedreich ataxia, most patients have progressive truncal and extremity ataxia, areflexia, positive Babinski...

Cite
Elkamil A, Johansen KK, Aasly J. Ataxia with vitamin e deficiency in norway. J Mov Disord. 2015;8(1):33-6doi: 10.14802/jmd.14030.
Elkamil, A., Johansen, K. K., & Aasly, J. (2015). Ataxia with vitamin e deficiency in norway. Journal of movement disorders, 8(1), 33-6. https://doi.org/10.14802/jmd.14030
Elkamil, Areej, et al. "Ataxia with vitamin e deficiency in norway." Journal of movement disorders vol. 8,1 (2015): 33-6. doi: https://doi.org/10.14802/jmd.14030
Elkamil A, Johansen KK, Aasly J. Ataxia with vitamin e deficiency in norway. J Mov Disord. 2015 Jan;8(1):33-6. doi: 10.14802/jmd.14030. Epub 2015 Jan 13. PMID: 25614784; PMCID: PMC4298717.
Copy Download .nbib Format: NLM
Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan.

Journal of drug delivery

Mustafa S, Devi VK, Pai RS.
PMID: 28352475
J Drug Deliv. 2017;2017:1253294. doi: 10.1155/2017/1253294. Epub 2017 Mar 02.

Kanamycin sulphate (KS) is a

Cite
Mustafa S, Devi VK, Pai RS. Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan. J Drug Deliv. 2017;2017:1253294doi: 10.1155/2017/1253294.
Mustafa, S., Devi, V. K., & Pai, R. S. (2017). Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan. Journal of drug delivery, 20171253294. https://doi.org/10.1155/2017/1253294
Mustafa, Sanaul, et al. "Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan." Journal of drug delivery vol. 2017 (2017): 1253294. doi: https://doi.org/10.1155/2017/1253294
Mustafa S, Devi VK, Pai RS. Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan. J Drug Deliv. 2017;2017:1253294. doi: 10.1155/2017/1253294. Epub 2017 Mar 02. PMID: 28352475; PMCID: PMC5352902.
Copy Download .nbib Format: NLM
Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial.

The journal of prevention of Alzheimer's disease

Abner EL, Kryscio RJ, Caban-Holt AM, Schmitt FA.
PMID: 26180776
J Prev Alzheimers Dis. 2015 Mar;2(1):11-16. doi: 10.14283/jpad.2015.37.

BACKGROUND: Subjective memory complaints reflect patient-identified deficits in memory and have been linked to increased risk of future dementia in nondemented (including cognitively intact) older adults.OBJECTIVES: To assess the risk of incident dementia during follow-up for participants in the...

Cite
Abner EL, Kryscio RJ, Caban-Holt AM, et al. Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial. J Prev Alzheimers Dis. 2015;2(1):11-16doi: 10.14283/jpad.2015.37.
Abner, E. L., Kryscio, R. J., Caban-Holt, A. M., & Schmitt, F. A. (2015). Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial. The journal of prevention of Alzheimer's disease, 2(1), 11-16. https://doi.org/10.14283/jpad.2015.37
Abner, E L, et al. "Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial." The journal of prevention of Alzheimer's disease vol. 2,1 (2015): 11-16. doi: https://doi.org/10.14283/jpad.2015.37
Abner EL, Kryscio RJ, Caban-Holt AM, Schmitt FA. Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial. J Prev Alzheimers Dis. 2015 Mar;2(1):11-16. doi: 10.14283/jpad.2015.37. PMID: 26180776; PMCID: PMC4500536.
Copy Download .nbib Format: NLM
Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique.

Turkish journal of urology

Gevrek F, Erdemir F.
PMID: 29484222
Turk J Urol. 2018 Jan;44(1):16-23. doi: 10.5152/tud.2017.95752. Epub 2018 Jan 08.

OBJECTIVE: Cisplatin is an effective antineoplastic agent used in cancer therapy. However, the use of cisplatin is restricted due to its toxic side effects. Alleviation of its side effects which restricts cisplatin use is highly important. We aimed to...

Cite
Gevrek F, Erdemir F. Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turk J Urol. 2018;44(1):16-23doi: 10.5152/tud.2017.95752.
Gevrek, F., & Erdemir, F. (2018). Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turkish journal of urology, 44(1), 16-23. https://doi.org/10.5152/tud.2017.95752
Gevrek, Fikret, and Erdemir, Fikret. "Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique." Turkish journal of urology vol. 44,1 (2018): 16-23. doi: https://doi.org/10.5152/tud.2017.95752
Gevrek F, Erdemir F. Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique. Turk J Urol. 2018 Jan;44(1):16-23. doi: 10.5152/tud.2017.95752. Epub 2018 Jan 08. PMID: 29484222; PMCID: PMC5821277.
Copy Download .nbib Format: NLM
Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans).

Antioxidants (Basel, Switzerland)

Nukala U, Thakkar S, Krager KJ, Breen PJ, Compadre CM, Aykin-Burns N.
PMID: 29473853
Antioxidants (Basel). 2018 Feb 23;7(2). doi: 10.3390/antiox7020033.

Radiation countermeasures fall under three categories, radiation protectors, radiation mitigators, and radiation therapeutics. Radiation protectors are agents that are administered before radiation exposure to protect from radiation-induced injuries by numerous mechanisms, including scavenging free radicals that are generated by...

Cite
Nukala U, Thakkar S, Krager KJ, et al. Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans). Antioxidants (Basel). 2018;7(2)doi: 10.3390/antiox7020033.
Nukala, U., Thakkar, S., Krager, K. J., Breen, P. J., Compadre, C. M., & Aykin-Burns, N. (2018). Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans). Antioxidants (Basel, Switzerland), 7(2), . https://doi.org/10.3390/antiox7020033
Nukala, Ujwani, et al. "Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans)." Antioxidants (Basel, Switzerland) vol. 7,2 (2018). doi: https://doi.org/10.3390/antiox7020033
Nukala U, Thakkar S, Krager KJ, Breen PJ, Compadre CM, Aykin-Burns N. Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans). Antioxidants (Basel). 2018 Feb 23;7(2). doi: 10.3390/antiox7020033. PMID: 29473853; PMCID: PMC5836023.
Copy Download .nbib Format: NLM
Wear Behaviours and Oxidation Effects on Different UHMWPE Acetabular Cups Using a Hip Joint Simulator.

Materials (Basel, Switzerland)

Affatato S, Ruggiero A, Jaber SA, Merola M, Bracco P.
PMID: 29547536
Materials (Basel). 2018 Mar 16;11(3). doi: 10.3390/ma11030433.

Given the long-term problem of polyethylene wear, medical interest in the new improved cross-linked polyethylene (XLPE), with or without the adding of vitamin E, has risen. The main aim of this study is to gain further insights into the...

Cite
Affatato S, Ruggiero A, Jaber SA, et al. Wear Behaviours and Oxidation Effects on Different UHMWPE Acetabular Cups Using a Hip Joint Simulator. Materials (Basel). 2018;11(3)doi: 10.3390/ma11030433.
Affatato, S., Ruggiero, A., Jaber, S. A., Merola, M., & Bracco, P. (2018). Wear Behaviours and Oxidation Effects on Different UHMWPE Acetabular Cups Using a Hip Joint Simulator. Materials (Basel, Switzerland), 11(3), . https://doi.org/10.3390/ma11030433
Affatato, Saverio, et al. "Wear Behaviours and Oxidation Effects on Different UHMWPE Acetabular Cups Using a Hip Joint Simulator." Materials (Basel, Switzerland) vol. 11,3 (2018). doi: https://doi.org/10.3390/ma11030433
Affatato S, Ruggiero A, Jaber SA, Merola M, Bracco P. Wear Behaviours and Oxidation Effects on Different UHMWPE Acetabular Cups Using a Hip Joint Simulator. Materials (Basel). 2018 Mar 16;11(3). doi: 10.3390/ma11030433. PMID: 29547536; PMCID: PMC5873012.
Copy Download .nbib Format: NLM
Comparative study of phenolic compounds, vitamin E, and fatty acids compositional profiles in black seed-coated soybeans (Glycine Max (L.) Merrill) depending on pickling period in brewed vinegar.

Chemistry Central journal

Chung IM, Oh JY, Kim SH.
PMID: 29086850
Chem Cent J. 2017 Jul 18;11(1):64. doi: 10.1186/s13065-017-0298-9.

BACKGROUND: Pickled soybeans or vinegar beans have long been used as a folk remedy and also a supplemental nutritional source in Korea. In general the pickling process in vinegar improves the digestibility of soybeans as well as increases the...

Cite
Chung IM, Oh JY, Kim SH. Comparative study of phenolic compounds, vitamin E, and fatty acids compositional profiles in black seed-coated soybeans (Glycine Max (L.) Merrill) depending on pickling period in brewed vinegar. Chem Cent J. 2017;11(1):64doi: 10.1186/s13065-017-0298-9.
Chung, I. M., Oh, J. Y., & Kim, S. H. (2017). Comparative study of phenolic compounds, vitamin E, and fatty acids compositional profiles in black seed-coated soybeans (Glycine Max (L.) Merrill) depending on pickling period in brewed vinegar. Chemistry Central journal, 11(1), 64. https://doi.org/10.1186/s13065-017-0298-9
Chung, Ill-Min, et al. "Comparative study of phenolic compounds, vitamin E, and fatty acids compositional profiles in black seed-coated soybeans (Glycine Max (L.) Merrill) depending on pickling period in brewed vinegar." Chemistry Central journal vol. 11,1 (2017): 64. doi: https://doi.org/10.1186/s13065-017-0298-9
Chung IM, Oh JY, Kim SH. Comparative study of phenolic compounds, vitamin E, and fatty acids compositional profiles in black seed-coated soybeans (Glycine Max (L.) Merrill) depending on pickling period in brewed vinegar. Chem Cent J. 2017 Jul 18;11(1):64. doi: 10.1186/s13065-017-0298-9. PMID: 29086850; PMCID: PMC5515724.
Copy Download .nbib Format: NLM
Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver.

Toxicological research

Heidari R, Esmailie N, Azarpira N, Najibi A, Niknahad H.
PMID: 27123164
Toxicol Res. 2016 Apr;32(2):133-40. doi: 10.5487/TR.2016.32.2.133. Epub 2016 Apr 30.

Sulfasalzine is a widely administered drug against inflammatory-based disorders in human. However several cases of liver injury are associated with its administration. There is no stabilized safe protective agent against sulfasalazine-induced liver injury. Current investigation was designed to evaluate...

Cite
Heidari R, Esmailie N, Azarpira N, et al. Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver. Toxicol Res. 2016;32(2):133-40doi: 10.5487/TR.2016.32.2.133.
Heidari, R., Esmailie, N., Azarpira, N., Najibi, A., & Niknahad, H. (2016). Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver. Toxicological research, 32(2), 133-40. https://doi.org/10.5487/TR.2016.32.2.133
Heidari, Reza, et al. "Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver." Toxicological research vol. 32,2 (2016): 133-40. doi: https://doi.org/10.5487/TR.2016.32.2.133
Heidari R, Esmailie N, Azarpira N, Najibi A, Niknahad H. Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver. Toxicol Res. 2016 Apr;32(2):133-40. doi: 10.5487/TR.2016.32.2.133. Epub 2016 Apr 30. PMID: 27123164; PMCID: PMC4843982.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 2750 entries